Breakthrough in photoactivatable nanomedicine for the treatment of age-related macular degeneration
Date | 5th, Dec 2023 |
---|---|
Source | ScienceDaily - General News Websites |
DESCRIPTION
Researchers have developed a light-activatable prodrug nanomedicine for age-related macular degeneration (AMD) therapy. Through the intravenous injection of the nanomedicine and application of light irradiation to diseased eyes, anti-angiogenic and photodynamic combination therapy can be activated, offering a minimally invasive alternative for the treatment of AMD and other ocular disorders characterized by abnormal blood vessel growth.